Search Result "Hormone-refractory"
Novel Biological Agents for the Treatment of Hormone-Refractory Prostate Cancer (HRPC)
Journal: Current Medicinal Chemistry
Volume: 12 Issue: 3 Year: 2005 Page: 277-296
Author(s): A. G. Papatsoris, M. V. Karamouzis, A. G. Papavassiliou
The Androgen Receptor as Putative Therapeutic Target in Hormone-Refractory Prostate Cancer
Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 2 Issue: 3 Year: 2007 Page: 203-211
Author(s): Yukio Kageyama, Nobuhiko Hyochi, Kazunori Kihara, Hiroshi Sugiyama
The Androgen Receptor as Putative Therapeutic Target in Hormone-Refractory Prostate Cancer
Ebook: Frontiers in Anti-Cancer Drug Discovery
Volume: 1 Year: 2010
Author(s): Yukio Kageyama, Nobuhiko Hyochi, Kazunori Kihara, Hiroshi Sugiyama
Doi: 10.2174/978160805161811001010481
Cabazitaxel: A Novel Drug for Hormone-Refractory Prostate Cancer
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 13 Issue: 6 Year: 2013 Page: 915-920
Author(s): Manav Malhotra, Richa Dhingra, Tina Sharma, Aakash Deep, Balasubramanian Narasimhan, Priyanka Phogat, Prabodh Chander Sharma
“Antisurvival” Factor Treatment for Hormone Refractory Prostate Cancer: Secondary Hormonal Ablation Using Somatostatin Analogs
Journal: Current Cancer Therapy Reviews
Volume: 7 Issue: 1 Year: 2011 Page: 56-64
Author(s): David Schilling, Rainer Kufer, Stephan Kruck, Sandra Waalkes, Arnulf Stenzl, Markus A. Kuczyk, Axel S. Merseburger
Prospective Trial of an Herbal Formula BYSH and Saw Palmetto in Patients with Hormonal Refractory Prostate Cancer: A Pilot Study
Journal: Recent Patents on Inflammation & Allergy Drug Discovery
Volume: 8 Issue: 3 Year: 2014 Page: 196-202
Author(s): Anthony C.-F. Ng, K.-F. Cheng, P.-C. Leung
Prostate Cancer: Biology, Incidence, Detection Methods, Treatment Methods, and Vaccines
Journal: Current Topics in Medicinal Chemistry
Volume: 20 Issue: 10 Year: 2020 Page: 847-854
Author(s): Ronald Bartzatt
Chemotherapy for Prostate Cancer
Journal: Current Pharmaceutical Design
Volume: 12 Issue: 7 Year: 2006 Page: 819-837
Author(s): Sara W. Dyrstad, Prabodh Shah, K. Rao
Antiproliferative Efficacy of Angiotensin II Receptor Blockers in Prostate Cancer
Journal: Current Cancer Drug Targets
Volume: 5 Issue: 5 Year: 2005 Page: 307-323
Author(s): Hiroji Uemura, Noboru Nakaigawa, Hitoshi Ishiguro, Yoshinobu Kubota
Ligustrazine Suppresses the Growth of HRPC Cells through the Inhibition of Cap- Dependent Translation Via Both the mTOR and the MEK/ERK Pathways
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 15 Issue: 6 Year: 2015 Page: 764-772
Author(s): Jiaoyan Han,Jiao Song,Xiangyun Li,Ming Zhu,Wei Guo,Wei Xing,Rongshen Zhao,Xiao He,Xiaoping Liu,Shali Wang,Yunyun Li,Hong Huang,Xiang Xu